# Global Life Science Ventures: portfolio, investments and team > Global Life Science Ventures is a growth equity based in Germany. 22 investments on record, latest Jan 2015. Portfolio, stages, co-investors and team. Source: https://millionrounds.com/fund/global-life-science-ventures (Millionrounds; every figure on the page links to its filing or article) Germany · [Investor](https://millionrounds.com/investors) # Global Life Science Ventures Last cheque observed Jan 2015. Silence since then is not evidence of inactivity: our sources miss unannounced rounds. Quiet Growth equity Series B Series C Series A Manufacturing Software Venture Capital & Private Equity Cheques on record **0%** of best year **0** **cheques in 12 months**, 22 on record Since the last cheque **4288** days **00** hrs **00** min **00** sec Median round **$20M** Rounds led **0 of 22** Exits **7 from the portfolio** Mostly in **United States, 29%** Pitch Global Life Science Ventures ## Global Life Science Ventures highlights - 01 22 rounds on record - 02 Mostly Series B and Series C: 50% of its rounds - 03 7 exits from the portfolio ## What they do - **Type:** Growth equity (from a list, unverified) - **Cheque size:** Not stated - **Sectors:** Manufacturing Software Venture Capital & Private Equity - **Based in:** Muenchen, Germany - **Cold pitches:** Not stated ## The record Every round we can evidence, newest first **22 appearances** - **2015** 1 round - **Jan** **[Atlas Genetics](https://millionrounds.com/company/atlas-genetics)** Series C · GB **$20M** With 5 others - **2014** 1 round - **Nov** **[PIERIS Proteolab](https://millionrounds.com/company/pieris-proteolab)** **$8.2M** With 5 others - **2012** 1 round - **Jun** **[Santaris Pharma](https://millionrounds.com/company/santaris-pharma)** Venture · DK · pevc.dowjones.com **$12M** With 5 others - **2010** 1 round - **Jul** **[Action Pharma](https://millionrounds.com/company/action-pharma)** Series C · DK · onbiovc.com **$6.3M** With 3 others - **2009** 2 rounds - **Dec** **[Coapt Systems](https://millionrounds.com/company/coapt-systems)** Debt · US · deals.venturebeat.com **$3.7M** With 7 others - **Sept** **[Agendia](https://millionrounds.com/company/agendia)** Series E · NL · fiercebiotech.com **$23M** With 3 others - **2008** 1 round - **Mar** **[PIERIS Proteolab](https://millionrounds.com/company/pieris-proteolab)** Series B · DE · pieris-ag.com **$39M** With 4 others - **2007** 4 rounds - **Dec** **[Santaris Pharma](https://millionrounds.com/company/santaris-pharma)** Series C · DK **$30M** With 7 others - **Aug** **[Agendia](https://millionrounds.com/company/agendia)** Series D · NL · agendia.com **$34M** With 2 others - **Mar** **[Nitec Pharma AG](https://millionrounds.com/company/nitec-pharma-ag)** Series B · CH **$26M** With 2 others - **Mar** **[Coapt Systems](https://millionrounds.com/company/coapt-systems)** Series E · US · deals.venturebeat.com **$23M** With 6 others - **2006** 2 rounds - **Nov** **[PIERIS Proteolab](https://millionrounds.com/company/pieris-proteolab)** Series B · DE **$6.4M** With 4 others - **Oct** **[Intelligent Medical Implants Ltd](https://millionrounds.com/company/intelligent-medical-implants-ltd)** Series B **$19M** With 3 others - **2005** 1 round - **Dec** **[NeurogesX](https://millionrounds.com/company/neurogesx)** Series D · US **$20M** With 5 others - **2004** 2 rounds - **Mar** **[Zalicus](https://millionrounds.com/company/zalicus)** Series C · US **$30M** With 6 others - **Mar** **[CareX SA](https://millionrounds.com/company/carex-sa)** Series B · FR **$32M** With 5 others - **2003** 4 rounds - **Nov** **[Glycart Biotechnology AG](https://millionrounds.com/company/glycart-biotechnology-ag)** Series A **$14M** With 5 others - **Aug** **[Coley Pharmaceutical Group](https://millionrounds.com/company/coley-pharmaceutical-group)** Venture · US **$30M** With 3 others - **Jul** **[Intercell](https://millionrounds.com/company/intercell)** Series C · AT **$34M** With 5 others - **Jul** **[Cyberkinetics](https://millionrounds.com/company/cyberkinetics)** Series A **$4.3M** With 2 others - **2002** 2 rounds - **Nov** **[PIERIS Proteolab](https://millionrounds.com/company/pieris-proteolab)** Series A **$12M** With 4 others - **Oct** **[Pieris AG](https://millionrounds.com/company/pieris-ag)** Series A · DE **$12M** With 5 others An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor. ## The team We hold **2** people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them. ## Exits from the portfolio Companies it backed that were later bought or listed **7 in all** **[Santaris Pharma](https://millionrounds.com/company/santaris-pharma)** Bought by Roche **$450M** Aug 2014 **[Intercell](https://millionrounds.com/company/intercell)** Bought by Vivalis **Undisclosed** Dec 2012 **[Coapt Systems](https://millionrounds.com/company/coapt-systems)** Bought by MicroAire **Undisclosed** Aug 2010 **[Coley Pharmaceutical Group](https://millionrounds.com/company/coley-pharmaceutical-group)** Bought by [Pfizer](https://millionrounds.com/fund/pfizer) **Undisclosed** Nov 2007 **[NeurogesX](https://millionrounds.com/company/neurogesx)** Listed **Undisclosed** Feb 2007 **[CareX SA](https://millionrounds.com/company/carex-sa)** Bought by 7TM Pharma **Undisclosed** May 2006 **[Glycart Biotechnology AG](https://millionrounds.com/company/glycart-biotechnology-ag)** Bought by Roche **Undisclosed** Jul 2005 An exit counts when it came after the firm's first round in the company. From historical deal records. ## The cheque Series B Series C Series A Median round joined **$20M** the round, not its cheque Led 0 of 22 rounds **0%** - **Sole investor:** Never alone - **Last cheque:** Jan 2015 - **Exits:** 7 from the portfolio Rounds by stage said on their site - Series B *5* - Series C *5* - Series A *4* - Venture *2* - Series D *2* - Series E *2* Cheques by year Led Joined 2002 2015 Often in the room with - [Gilde Healthcare](https://millionrounds.com/fund/gilde-healthcare) 8 - [BayTech Venture Capital](https://millionrounds.com/fund/baytech-venture-capital) 4 - [Alta Partners](https://millionrounds.com/fund/alta-partners) 3 - [Boston Millennia Partners](https://millionrounds.com/fund/boston-millennia-partners) 3 - [Canaan](https://millionrounds.com/fund/canaan-partners) 3 - [Easton Capital](https://millionrounds.com/fund/easton-capital-investment-group) 3 **Pitching Global Life Science Ventures?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque. Add to your CRM *→* ## Who they invest alongside The investors most often in the same rounds as Global Life Science Ventures. A count of rooms they were both in, not a relationship either has claimed. [**Gilde Healthcare** Private equity **8** rounds together](https://millionrounds.com/fund/gilde-healthcare)[**BayTech Venture Capital** VC firm **4** rounds together](https://millionrounds.com/fund/baytech-venture-capital)[**Alta Partners** VC firm **3** rounds together](https://millionrounds.com/fund/alta-partners)[**Boston Millennia Partners** Private equity **3** rounds together](https://millionrounds.com/fund/boston-millennia-partners)[**Canaan** VC firm **3** rounds together](https://millionrounds.com/fund/canaan-partners)[**Easton Capital** VC firm **3** rounds together](https://millionrounds.com/fund/easton-capital-investment-group)[**Forbion Capital Partners** Private equity **3** rounds together](https://millionrounds.com/fund/forbion-capital-partners)[**Sunstone Life Science Ventures** VC firm **3** rounds together](https://millionrounds.com/fund/sunstone-life-science-ventures)[**ABN AMRO Fund** Corporate VC **2** rounds together](https://millionrounds.com/fund/abn-amro-clearing)[**Asset Management Ventures** VC firm **2** rounds together](https://millionrounds.com/fund/asset-management-ventures)[**BioM Venture Capital** VC firm **2** rounds together](https://millionrounds.com/fund/biom-venture-capital)[**BioMedInvest** Growth equity **2** rounds together](https://millionrounds.com/fund/biomedinvest) ## Quick answers about Global Life Science Ventures ### What does Global Life Science Ventures invest in? Global Life Science Ventures invests most often at Series B and Series C (50% of the rounds on record), in sectors such as Manufacturing, Software and Venture Capital & Private Equity. ### How active is Global Life Science Ventures? 22 investments on record, 0 of them in the last 12 months. The most recent was in Jan 2015. ### How big are Global Life Science Ventures's cheques? The median round it joins is $20M. ### Does Global Life Science Ventures lead rounds? Rarely, if at all: none of its 22 investments on record names it as the lead. ### Where does Global Life Science Ventures invest? Most of the companies it backs are in the United States (29%), Denmark (18%) and Germany (18%). ### Is Global Life Science Ventures investing now? No investments in the last 12 months; the latest was in Jan 2015. ### Who does Global Life Science Ventures invest alongside? Most often Gilde Healthcare (8 rounds together), BayTech Venture Capital (4 rounds together) and Alta Partners (3 rounds together). ### What kind of investor is Global Life Science Ventures? Global Life Science Ventures is a growth equity firm based in Muenchen, Germany. ## Raising now? Find the investors who back rounds like yours, and keep every conversation on one fundraising board. Find similar investorsOpen your CRM Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=global-life-science-ventures) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=global-life-science-ventures)